Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION AS FIRST TRANSPLANT AFTER CHECKPOINT INHIBITORS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN’S LYMPHOMA

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Carmen Martínez

Comparison of allogeneic hematopoietic stem cell transplantation (HCT) with CAR T-cells in relapsed and refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma (PMBCL)

Études rétrospectives

Lymphome non hodgkinien (LNH)

GoCART Coalition

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Practice patterns of holding and bridging therapy for mantle cell lymphoma patients in the CAR T-cell setting

Closed Survey/Study

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Gloria Iacoboni, MD, PhD, Pere Barba, MD, PhD

Long-term survival after autologous or allogeneic transplantation for T-cell lymphoma: a retrospective analysis of the EBMT-Lymphoma Working Party

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Outcomes of Autologous and Allogeneic Stem Cell Transplantation in Patients with Hepatosplenic T-cell Lymphoma (HSTCL)

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Imke E. Karsten

Comparison of the outcomes of patients with mantle cell lymphoma after CAR T cell therapy in the ZUMA-2 collective versus allogeneic stem cell transplantation

Études rétrospectives

Leucémie Myéloïde Chronique (LMC)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Prof. Dr. Sascha Dietrich, Dr. Nora Liebers

Allogeneic Hematopoietic Cell Transplantation and CAR-T therapy for T-cell/histiocyte-rich Large B-cell Lymphoma (THRLBCL) A Retrospective Study of the EBMT Lymphoma Working Party

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Simon Renders, MD

Trends in Hematopoietic Stem Cell Transplantation for Patients with Diffuse Large B-Cell Lymphoma. A Retrospective Analysis of the Lymphoma WP of the EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Norbert Schmitz, Anna Sureda

Efficacy and toxicity of CAR T cell therapy in patients with primary and secondary central nervous system lymphoma

Études rétrospectives

Lymphome non hodgkinien (LNH)

GoCART Coalition

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Anna Ossami Saidy

Post-transplantation cyclophosphamide-based after HLA-matched versus haploidentical donor transplants in patients with Hodgkin lymphoma: a comparative study of the LWP EBMT

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type de traitement

Allogénique - Haplo-identique

Investigateur principal

Dr. Juan Montoro

Real life analysis BV use as consolidation therapy in HL with high risk post ASCT

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Mariana Bastos Oreiro

Outcomes of Allogeneic HCT in patients with Hodgkin Lymphoma in the era of Checkpoint Inhibitors: A joint CIBMTR and EBMT analysis.

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Miguel-Angel Perales